Bioniq Acquires Herbalife for $150M to Scale Personalized Health Supplements

Bioniq Acquires Herbalife for $150M to Scale Personalized Health Supplements

How Bioniq’s Technology Drives Personalized Health Supplements

Bioniq, a leader in personalized health supplements, has made waves by acquiring Herbalife for $150 million. Founded in 2019, Bioniq uses blood biomarker analysis to create tailored supplement formulas. Its patented algorithm identifies micronutrient imbalances, offering precision nutrition for everyday users and elite athletes alike.

Blood Biomarker Analysis for Tailored Formulations

By analyzing over 6 million data points from five continents, Bioniq’s platform delivers actionable health insights. Customers receive one-on-one consultations and ongoing support, ensuring their supplements align with their unique health profiles. This science-driven approach has positioned Bioniq as a pioneer in measurable, personalized nutrition.

Expanding Access Through Global Partnerships

Backed by investors like Cristiano Ronaldo and Diogo Dalot, Bioniq has expanded to 70 markets, including the UAE and Saudi Arabia. Strategic partnerships with entities like Al Borg Diagnostics have accelerated its growth, proving the demand for data-backed health solutions.

The Strategic Move: Bioniq Acquires Herbalife for $150M

The acquisition includes an initial $10 million payment, with up to $95 million in future performance-based incentives. Vadim Fedotov, Bioniq’s founder, will join Herbalife’s leadership team, ensuring a seamless integration of Bioniq’s technology into Herbalife’s global network.

Financial Terms and Leadership Transition

Key Bioniq team members will transition to Herbalife, leveraging the company’s 2 million distributors across 95 markets. This partnership accelerates Bioniq’s mission to make personalized health accessible worldwide.

Accelerating Global Reach with Herbalife’s Infrastructure

Herbalife’s Pro2col platform and global distribution channels will scale Bioniq’s offerings. The integration of Bioniq’s algorithm and formulation capabilities promises innovative products for millions of consumers, starting in Europe and the U.S.

Future of Personalized Health Supplements

Cristiano Ronaldo, a longtime user of both brands, highlights the power of tailored nutrition. “Personalized supplements optimize performance and wellness,” he says. Herbalife’s CEO Stephan Gratziani adds, “This merger defines the future of data-driven health.”

Expanding Markets and Product Launches

Bioniq’s supplements will launch through Herbalife distributors in select countries later this year. The transaction, expected to close in Q2 2026, also includes a call option for Bioniq LAB, focusing on peptides and small molecules.

Why This Acquisition Matters

  • Scalability: Herbalife’s global reach ensures Bioniq’s technology reaches millions.
  • Innovation: Combining Bioniq’s science with Herbalife’s resources drives product evolution.
  • Trust: Backed by elite athletes and top investors, the partnership reinforces credibility.

Conclusion: A New Era for Personalized Health

Bioniq’s acquisition of Herbalife marks a pivotal shift in health tech. By merging cutting-edge biomarker analysis with global distribution, the partnership redefines how people access personalized nutrition. Stay tuned for more updates on this transformative journey!